Why Choose Private Prescription Over NHS Route?
Private vs NHS: Speed and Accessibility
NHS waiting lists for weight management treatments can extend for months, leaving patients frustrated and delayed. Private prescription through EverydayMeds eliminates these barriers, offering clinical assessment and approval within 3 working days. For urgent access, our express service provides 24-hour approval, getting you started on Mounjaro treatment immediately.
Transparent Private Prescription Pricing
Our private Mounjaro pricing starts from £129.99 for 2.5mg starter pens (first order with FIRST40 code). Single pen options range from £129.99 to £278.99 depending on strength, with convenient bundle packages available. The Intro Duo (2.5mg + 5mg) costs £299.99 for first orders, providing seamless dose progression. All prices include clinical assessment and prescription fees.
Streamlined Private Assessment Process
Our private clinical assessment eliminates NHS bureaucracy whilst maintaining safety standards. Complete your medical questionnaire online, receive prescription approval, and order genuine Mounjaro directly. This prescription-only treatment requires clinical oversight, which our registered prescribers provide without NHS delays or postcode lottery restrictions.
Genuine UK-Sourced Mounjaro Supply
EverydayMeds sources authentic Mounjaro through licensed UK wholesalers, ensuring product authenticity and proper cold-chain storage. Our GPhC-registered pharmacy ensures genuine tirzepatide medication, not grey market imports. Each pen contains the exact dosage prescribed, supporting your weight management journey alongside reduced-calorie diet and increased physical activity.
Ongoing Support Without NHS Restrictions
Private prescription patients receive continuous support throughout their Mounjaro journey. Returning customers save £25 on every order, making long-term treatment affordable. Dose adjustments and prescription renewals happen quickly through our private service, without NHS appointment delays or eligibility reassessments that may interrupt treatment continuity.
